National Market Access Lead (m/w/d)

Lead the development and execution of national market access strategies for vaccines and pipeline therapeutics [2, 3],Own pricing and contracting approaches, ensuring alignment with global/regional frameworks and German policy [2, 3],Shape national HTA and reimbursement positioning, including readiness for evolving policy requirements [2, 3],Oversee national dossier development and submission processes (e.g., AMNOG/§35a SGB V), ensuring robust, evidence-based access narratives [2, 3],Serve as Moderna's lead representative to key national health institutions and payers (G-BA, RKI, GKV-SV, and STIKO) [2, 3],Shape national HTA submissions [2, 3],Develop evidence-driven payer value propositions [2, 3],Translate complex clinical and economic data into strategic outcomes [2, 3],Work cross-functionally and globally [2, 3]

Deep expertise in German access pathways and reimbursement systems [4],Proven experience engaging with national HTA and public health stakeholders [4],Strong analytical capabilities with hands-on expertise in real-world evidence analysis [4],Strong command of Germany's HTA, pricing, and claims-based systems [2, 3],Ability to translate complex clinical and economic data into strategic outcomes [2, 3]

Moderna provides comprehensive support for its employees and their families. While a specific list of benefits is not publicly available, the company emphasizes its commitment to the well-being of its team. Benefits include paid time off for volunteering and support for community career development.

Externally facing, requiring direct interaction with health authorities and decision-makers [2, 3],Serve as Moderna's lead representative to key national health institutions and payers [2, 3]